Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
ACADM Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACADM, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACADL Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACADL, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACAD11 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACAD11, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
PGM1-congenital disorder of glycosylation Indication Strategy Report 2026: PGM1, Trials and Deals
23 July 2026
2026 PGM1-congenital disorder of glycosylation strategy: epidemiology, PGM1 biology, clinical competition, recent deals, unmet need and market attractiveness.
8 min read
ACAD10 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACAD10, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACAD9 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACAD9, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACAD8 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACAD8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACAA2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACAA2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ACAA1 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ACAA1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABTB3 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABTB3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
ABTB2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
23 July 2026
A visual target evaluation report for ABTB2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
CLN3 disease Indication Strategy Report 2026: CLN3, Trials and Deals
23 July 2026
2026 CLN3 disease strategy: epidemiology, CLN3 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized with…